Skip to content

Obesity Intervention Obeldicks for Obese Children, Adolescents and Their Parents

Evaluation of the Intervention Program Obeldicks for Obese Children and Adolescents

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00435734
Acronym
Obeldicks
Enrollment
4000
Registered
2007-02-15
Start date
1999-07-31
Completion date
2030-12-31
Last updated
2020-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The intervention program Obeldicks was developed for obese children aged 6 to 16 years. This intervention is gender- and age specific. The 12-months intervention is based on nutrition course, behaviour therapy and exercise therapy. The evaluation compromised quality of structure, process and results of the intervention. Primary outcome measure is change of weight status as standard deviation score of BMI. Furthermore, cardiovascular risk factor profile, hormones (e.g. iGF-I, thyroid hormones, vitamin D status)adipocytokines, GI- hormones, intima media thickness are measured prior to and after the one-year intervention. The changes of these hormones and adipocytokines will allow to answer the questions whether the alterations of these hormones are a cause or consequence of overweight. Additionally, a genetic screening is performed to characterize the participants to probably predict response to intervention.

Interventions

BEHAVIORALobesity intervention

Sponsors

University of Witten/Herdecke
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI\> 97. percentile for age and gender

Exclusion criteria

* Psychiatric disorders * Endocrine disorders

Design outcomes

Primary

MeasureTime frame
change of BMI-SDS20 years

Secondary

MeasureTime frame
change of GI hormones10 years
change of adipocytokines10 years
change of cardiovascualr risk factors10 years
change of metabolomics10 years
change of psychological variables10 years

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026